Westport (WPRT) reported earnings 30 days ago. What's next for the stock?

NEW YORK, NY / ACCESS Newswire / June 12, 2025 / If you suffered a loss on your Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/iovance-biotherapeutics-inc-lawsuit-submission-form?prid=152824&wire=1&utm_campaign=21 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / June 12, 2025 / If you suffered a loss on your UroGen Pharma Ltd. (NASDAQ:URGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/urogen-pharma-ltd-lawsuit-submission-form?prid=152831&wire=1&utm_campaign=22 or contact Joseph E.

NEW YORK, NY / ACCESS Newswire / June 12, 2025 / If you suffered a loss on your Organon & Co. (NYSE:OGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/organon-co-lawsuit-submission-form?prid=152832&wire=1&utm_campaign=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / June 12, 2025 / If you suffered a loss on your Open Lending Corporation (NASDAQ:LPRO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/open-lending-corporation-lawsuit-submission-form?prid=152829&wire=1&utm_campaign=30 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / June 12, 2025 / If you suffered a loss on your Fortrea Holdings Inc. (NASDAQ:FTRE) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/fortrea-holdings-inc-lawsuit-submission-form?prid=152825&wire=1&utm_campaign=16 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / June 12, 2025 / If you suffered a loss on your Red Cat Holdings, Inc. (NASDAQ:RCAT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/red-cat-holdings-inc-lawsuit-submission-form?prid=152827&wire=1&utm_campaign=22 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / June 12, 2025 / If you suffered a loss on your Civitas Resources, Inc. (NYSE:CIVI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/civitas-resources-lawsuit-submission-form?prid=152828&wire=1&utm_campaign=17 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / June 12, 2025 / If you suffered a loss on your Ibotta, Inc. (NYSE:IBTA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/ibotta-lawsuit-submission-form?prid=152830&wire=1&utm_campaign=30 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / June 12, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Gilead Sciences, Inc. ("Gilead Sciences, Inc.") (NASDAQ:GILD) concerning possible violations of federal securities laws. Gilead issued a press release on June 10, 2025, announcing that "[t]he U.S. Food and Drug Administration has placed a clinical hold on Gilead's HIV treatment trials of GS-1720 (an investigational integrase strand transfer inhibitor) and/or GS-4182 (an investigational capsid inhibitor)[,]" specifying that "[t]he clinical hold is due to the identification of a safety signal of decreases in CD4+T-cell (CD4) and absolute lymphocyte …

NEW YORK, NY / ACCESS Newswire / June 12, 2025 / If you suffered a loss on your DoubleVerify Holdings, Inc. (NYSE:DV) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/doubleverify-holdings-inc-lawsuit-submission-form-2?prid=152826&wire=1&utm_campaign=26 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / June 12, 2025 / Levi & Korsinsky, LLP is investigating potential claims on behalf of California residents, who are account holders with eBay and visited eBay's website at https://www.ebay.com. Levi & Korsinsky, LLP's investigation indicates that legally protected data may have been unlawfully intercepted during visits to eBay's website, particularly affecting users who are California residents and are account holders with eBay.

NEW YORK, NY / ACCESS Newswire / June 12, 2025 / If you suffered a loss on your Napco Security Technologies, Inc. (NASDAQ:NSSC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/napco-security-technologies-inc-lawsuit-submission-form-2?prid=152834&wire=1&utm_campaign=29 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / June 12, 2025 / If you suffered a loss on your Strategy Incorporated (NASDAQ:MSTR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/strategy-incorporated-lawsuit-submission-form?prid=152835&wire=1&utm_campaign=13 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / June 12, 2025 / If you suffered a loss on your Krispy Kreme, Inc. (NASDAQ:DNUT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/krispy-kreme-inc-lawsuit-submission-form?prid=152836&wire=1&utm_campaign=17 or contact Joseph E. Levi, Esq.

SAN FRANCISCO, June 12, 2025 (GLOBE NEWSWIRE) -- SelectQuote Inc. (NYSE: SLQT) faced renewed investor pressure on Monday, May 12, 2025, as its shares tumbled another 12% following the release of quarterly results that fell short of earnings and revenue expectations. This decline compounds the over 19% drop experienced on May 1st after the U.S. Department of Justice (DOJ) announced a lawsuit alleging violations of the False Claims Act against the insurance brokerage and several major health insurers.

The bulls have finally defended GCT's trading floor at the $11 range, after the painful -71.7% stock price decline between the May 2024 peaks and April 2025 bottom. Thanks to the 90-day tariff pause and the ongoing de-escalation in the trade war between the US and China, we may see sentiments further lift and GCT's valuation upgrade occur. This is significantly aided by the growing adoption of its marketplace offerings/ services and the intensified diversification to international regions/ other bulky offerings.

Philip Moriss is strategically evolving beyond its traditional cigarette business, exemplified by the remarkable success of its "Zyn" oral nicotine patch.

A London-bound Air India Boeing 787 Dreamliner aircraft holding 242 passengers and crew crashed in India. Boyd Group International president and Synovus vice president and senior portfolio manager Mike Boyd joins Morning Brief with Brad Smith to discuss the latest.

GS eyes growth in Japan's OCIO market as it pursues growth in asset management and tailored investment solutions.